ASX:IVX

Invion (IVX) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
471,000 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IVX stock logo

About Invion Stock (ASX:IVX)

Invion Limited, a clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of various cancers, atherosclerosis, and infectious diseases in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, anogenital, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to develop a novel photosensitiser for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.

IVX Stock News Headlines

InVision Software AG IVX
Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Stocks in August are DROPPING – Here’s Why
Gas Prices About to Skyrocket, Gas Economics 101
Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Doctor Who 1960s movies get price cut
Meta Sparks a Sharp Sell-off in Tech Stocks
Markets Today: Global Stocks Slide as Bond Yields Climb
Man charged in Indiana County home invasion
See More Headlines
Receive IVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invion and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-1,500,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.39 million

Miscellaneous

Outstanding Shares
6,420,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
1.20
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Thian Chew
    Executive Chairman & CEO
  • Ms. Melanie Jaye Leydin B.Bus (Age 51)
    C.A., Chief Financial Officer
  • Dr. Dean Naylor
    Head of Intellectual Property Development
  • Ms. Claire Newstead-Sinclair C.A.
    Company Secretary

IVX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Invion own?
This page (ASX:IVX) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners